Literature DB >> 24853024

Three cases of mesalazine-induced pneumonitis with eosinophilia.

Miyo Inoue1, Nobuyuki Horita2, Naoko Kimura3, Ryota Kojima4, Naoki Miyazawa5.   

Abstract

Oral mesalazine, or 5-aminosalicylate, is one of the first-choice medications for the treatment of ulcerative colitis and is commonly used for both induction and maintenance therapy. In a 6-month period, we treated three cases of mesalazine-induced pneumonitis. In all three cases, computed tomography images revealed upper lobe dominant bilateral peripherally localized consolidations. Such images are commonly observed in patients with cryptogenic organizing pneumonia or chronic eosinophilic pneumonia. Computed tomography images for mesalazine-induced pneumonitis have been rarely reported in the literature.
Copyright © 2014 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adverse effects; Inflammatory bowel disease; Interstitial pneumonia; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 24853024     DOI: 10.1016/j.resinv.2013.12.002

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  3 in total

1.  Mesalamine induced eosinophilic pneumonia.

Authors:  Ankit Gupta; Swati Gulati
Journal:  Respir Med Case Rep       Date:  2017-04-12

2.  Mesalazine-induced eosinophilic pneumonia with bone marrow infiltration: a case report and literature review.

Authors:  Yunjian Zhang; Ling Luo; Xiaofang Wang; Xiaoyang Liu; Xiaoyan Wang; Yi Ding
Journal:  Ther Clin Risk Manag       Date:  2016-06-14       Impact factor: 2.423

3.  Mesalazine-induced lung injury with severe respiratory failure successfully treated with steroids and non-invasive positive pressure ventilation.

Authors:  Hajime Oi; Atsushi Suzuki; Yasuhiko Yamano; Toshiki Yokoyama; Toshiaki Matsuda; Kensuke Kataoka; Yasuhiko Suzuki; Tomoki Kimura; Yasuhiro Kondoh
Journal:  Respir Med Case Rep       Date:  2020-08-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.